Page last updated: 2024-08-21

ethambutol and triclosan

ethambutol has been researched along with triclosan in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's3 (50.00)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Aínsa, JA; Martín, C; Ramón-García, S; Thompson, CJ1
Aminabhavi, TM; Dixit, SR; Joshi, SD; Kirankumar, MN; Lherbet, C; Narayan, R; Raju, KV; Yang, KS1
Aminabhavi, TM; Dixit, SR; Joshi, SD; Kumar, D; Lherbet, C; More, UA; Tigadi, N; Yang, KS1
Aminabhavi, TM; Dixit, SR; Joshi, SD; Kulkarni, VH; Lherbet, C; Nadagouda, MN1
Doğan, H; Doğan, ŞD; Gündüz, MG; Krishna, VS; Lherbet, C; Şahin, O; Sarıpınar, E; Sriram, D1
Doğan, H; Doğan, ŞD; Gündüz, MG; Krishna, VS; Lherbet, C; Sriram, D1

Other Studies

6 other study(ies) available for ethambutol and triclosan

ArticleYear
Role of the Mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:9

    Topics: Antitubercular Agents; Bacterial Proteins; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Clofazimine; Dithiothreitol; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Glutathione; Hydrogen Peroxide; Membrane Transport Proteins; Mutation; Mycobacterium tuberculosis; Oligonucleotide Array Sequence Analysis; Oxidative Stress; Rifampin; Valinomycin

2009
Synthesis, antimycobacterial screening and ligand-based molecular docking studies on novel pyrrole derivatives bearing pyrazoline, isoxazole and phenyl thiourea moieties.
    European journal of medicinal chemistry, 2016, Jan-01, Volume: 107

    Topics: Anti-Bacterial Agents; Antitubercular Agents; Bacterial Proteins; Chemistry Techniques, Synthetic; Drug Evaluation, Preclinical; Enzyme Inhibitors; Escherichia coli; Humans; Isoxazoles; Ligands; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Oxidoreductases; Pyrroles; Staphylococcus aureus; Thiourea

2016
Synthesis, characterization and antitubercular activities of novel pyrrolyl hydrazones and their Cu-complexes.
    European journal of medicinal chemistry, 2016, Oct-04, Volume: 121

    Topics: A549 Cells; Anti-Bacterial Agents; Antitubercular Agents; Cells; Coordination Complexes; Copper; Humans; Hydrazones; Ligands; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Quantitative Structure-Activity Relationship

2016
Synthesis, biological evaluation and in silico molecular modeling of pyrrolyl benzohydrazide derivatives as enoyl ACP reductase inhibitors.
    European journal of medicinal chemistry, 2017, Jan-27, Volume: 126

    Topics: Anti-Bacterial Agents; Bacteria; Binding Sites; Cell Line, Tumor; Chemistry Techniques, Synthetic; Computer Simulation; Drug Design; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Protein Conformation; Pyrroles

2017
Discovery of hydrazone containing thiadiazoles as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors.
    European journal of medicinal chemistry, 2020, Feb-15, Volume: 188

    Topics: Animals; Antitubercular Agents; Bacterial Proteins; Cell Survival; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Discovery; Enzyme Inhibitors; Hydrazones; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Oxidoreductases; RAW 264.7 Cells; Structure-Activity Relationship; Thiadiazoles

2020
Design and synthesis of thiourea-based derivatives as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors.
    European journal of medicinal chemistry, 2020, Aug-01, Volume: 199

    Topics: Animals; Antitubercular Agents; Bacterial Proteins; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Macrophages; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Oxidoreductases; RAW 264.7 Cells; Structure-Activity Relationship; Thiourea

2020